Effect of catecholamines and dibutyryl-cyclic-AMP on glucose turnover, plasma free fatty acids, and insulin in dogs treated with methylprednisolone.
D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology*; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005947:Glucose / Q000378:metabolism*; D007328:Insulin / Q000097:blood*; D007700:Kinetics; D007773:Lactates / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008433:Mathematics; D008775:Methylprednisolone / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D011863:Radioimmunoassay; D013053:Spectrophotometry; D013997:Time Factors; D014316:Tritium
D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007773:Lactates; D014316:Tritium; D000242:Cyclic AMP; D005947:Glucose; D009638:Norepinephrine; D008775:Methylprednisolone; D004837:Epinephrine